Trials / Unknown
UnknownNCT05047159
The Role of Neuromodulation Technique In Depression Disorder
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 450 (estimated)
- Sponsor
- Shanghai Mental Health Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to explore the efficacy, safety and long-term effects of common and available non-invasive neuromodulation techniques in the treatment of depression, and to provide a data basis for the establishment of individualized treatment and efficacy prediction models. 450 patients will be enrolled and randomly assigned to five different treatments. Psychopathological assessment will be performed in both acute and maintenance phases of treatment with the Hamilton Depression Rating Scale, the Hamilton Anxiety Rating Scale, and the Patient Health Questionaire-9, the Sheehan Disability Scale, the Vascular Quality of Life-6 Questionnaire respectively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | rTMS | Stimulation will be performed for 20 working days once a day (4 weeks). Extend course to 30 sessions (6 weeks) in responders who have not achieved symptom remission. Frequency: 10Hz; Intensity: 110% RMT; Coil-type: F8; Sessions-pulse: 3000; Site: the left dorsolateral prefrontal cortex. |
| DEVICE | light therapy | Active 10,000-lux fluorescent white light box for 30 min/d in the early morning for 6 weeks. |
| DEVICE | ECT | The electrode placements are bifrontal (BF); the electrical intensity is 1.5 to 2.0 times the seizure threshold (ST); 3 times per week. |
| DEVICE | MST | A coil placement at the vertex (i.e., Cz in 10-20 electroencephalogram \[EEG\] system) with a frequency of stimulation of 100 Hz, pulse width of 0.2 to 0.4 ms, and stimulation duration of 10 seconds; 2 times per week. |
| DRUG | drug therapy | There is no restriction on the choice of therapeutic drugs. |
Timeline
- Start date
- 2022-11-01
- Primary completion
- 2024-03-30
- Completion
- 2024-06-30
- First posted
- 2021-09-16
- Last updated
- 2022-10-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05047159. Inclusion in this directory is not an endorsement.